Organisation paid for research Program year 2025 Source: CMS Open Payments

Intrepid Research, LLC.

Neither a doctor nor a teaching hospital

Research payments

$892,793

451 payments

Through program year 2025, Intrepid Research, LLC. is reported as receiving $892,793 in research payments, across 451 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2025	Research	$567,648	318
2024	Research	$325,145	133

Breakdown

Who paid Research payments · program years 2024–2025

Alkermes, Inc. $892,793 451 payments

Studies the money was for Research payments · program years 2024–2025

A Phase 2, Parallel-Group, Dose-Range-Finding Study With Randomized Double-Blind Treatment and Open-Label Periods to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Narcolepsy Type 2 $307,939 151 payments
A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia (Vibrance 3) $298,958 115 payments
A Phase 2, Parallel-Group, Dose-Range-Finding Study With Randomized Double-Blind Treatment and Open-Label Periods to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Narcolepsy Type 1 $244,899 143 payments
An Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Durability of Treatment Effect of ALKS 2680 in Subjects With Narcolepsy Type 1 and Type 2 and Idiopathic Hypersomnia $40,996 42 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.